ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

 

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.


MDRTB: detection and management

Poster Discussion
Chairs: H. Kunst (London, United Kingdom), D. Chesov (Chisinau, Republic of Moldova)
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
M. Kale (Pune (Maharashtra), India)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Linezolid Experience Among MDR-TB Patients in Mumbai
R. Banka (MUMBAI (MAHARASHTRA), India)
Congress or journal article abstract
Congress or journal article abstract
Bedaquiline-containing regimens for chronic XDR-TB patients: up to 120 weeks after initiation
S. Borisov (Moscow, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
E. Nosova (Moscow, Russian Federation)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Rapid Detection of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis Strains Using Allele-specific PCR
G. Srivastava (Varanasi (Uttar Pradesh), India)
Congress or journal article abstract
Congress or journal article abstract
MDR-TB treatment efficacy according of conventional method and Xpert MTB/RIF results in Republic of Moldova.
A. Malic (Chisinau, Republic of Moldova)
Congress or journal article abstract
Congress or journal article abstract
Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis
L. Evelina (Chisinau, Republic of Moldova)
Congress or journal article abstract
Congress or journal article abstract
The efficiency of including the II-line drugs to the treatment regimen of isoniazid-resistant tuberculosis.
O. Hovardovska (Kharkiv, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013
N. KOBAYASHI (Kiyose, Tokyo, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Totally implantable central venous access ports for M/XDR-TB treatment
A. Skrahin (Minsk, Belarus)
Congress or journal article abstract
Congress or journal article abstract
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
M. Kuzhko (Kyiv, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
Video observed treatment for tuberculosis patients in Belarus
A. Skrahina (Minsk region, Belarus)
Congress or journal article abstract
Congress or journal article abstract
Retrospective case-control study of risk factors for recurrent tuberculosis in Singapore
S. Gan (Singapore, Singapore)
Congress or journal article abstract
Congress or journal article abstract
Changes in the lung in radiological studies in children with a positive tuberculin skin test.
P. Gavrilov (St Petersburg, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
The potentials of multi-slice computed tomography (MSCT) and single-photon emission computed tomography (SPECT) in differentiation of pulmonary granulomatoses
R. Amansahedov (Moscow, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
Express detection and differentiation of M. tuberculosis and nontuberculous mycobacteria in samples
A. Ergeshov (Staraya Kupavna, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract